SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (765)11/14/2003 6:05:03 AM
From: Icebrg  Respond to of 2240
 
MEDX and CEGE - sleeping with the enemy?

From the fresh 10Q filed by Medarex the following may be noted:

Pursuant to a May, 2003 research and development collaboration, the Company and Cell Genesys, Inc. expect to initiate a Phase I clinical study during the next year to evaluate combination therapy with Cell Genesys’ GVAX ® prostate cancer vaccine and our anti-CTLA-4 antibody. We expect that the cost of this clinical trial will be shared equally by both companies.


Erik


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News